OQS
EDIT icon

Occudo Quantitative Strategies’s Editas Medicine EDIT Stock Holding History

Occudo Quantitative Strategies’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-14,500
Closed -$113K – 895
2023
Q3 		$113K Buy
+14,500
New +$124K 0.01% 867
2022
Q4 		– Sell
-50,588
Closed -$619K – 1072
2022
Q3 		$619K Sell
50,588
-11,371
-18% -$177K 0.05% 592
2022
Q2 		$733K Buy
+61,959
New +$830K 0.06% 486
2022
Q1 		– Sell
-9,275
Closed -$246K – 1173
2021
Q4 		$246K Buy
+9,275
New +$319K 0.02% 832

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Occudo Quantitative Strategies's EDIT Position: Q4 2023 in Review

Occudo Quantitative Strategies sold out of Editas Medicine (EDIT) in Q4 2023, closing a stake of 14,500 shares — an estimated $113K sold.

Occudo Quantitative Strategies first reported a position in EDIT in Q4 2021 and held it in 4 quarters. The position peaked at $733K in Q2 2022. 225 funds tracked by Wall St. Rank hold EDIT as of Q4 2023.

  • Occudo Quantitative Strategies reported no remaining Editas Medicine position as of Q4 2023 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 14,500 Editas Medicine shares in Q4 2023, an estimated $113K.
  • Occudo Quantitative Strategies first reported a position in Editas Medicine in Q4 2021 and held it in 4 quarters.
  • Occudo Quantitative Strategies's Editas Medicine position peaked at $733K in Q2 2022.
  • 225 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2023.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2023, filed 14 Feb 2024.